User menu

Phase I-II study of a Farnesyl Transferase Inhibitor (FTI), SCH66336, in patients with myelodysplastic syndrome (MDS) or secondary acute myeloid leukemia (sAML).

Bibliographic reference Ravoet, C ; Mineur, P. ; Robin, V. ; Debusscher, L. ; Bosly, André ; et. al. Phase I-II study of a Farnesyl Transferase Inhibitor (FTI), SCH66336, in patients with myelodysplastic syndrome (MDS) or secondary acute myeloid leukemia (sAML)..44th Annual Meeting of the American-Society-of-Hematology (PHILADELPHIA(Pennsylvania), Dec 06-10, 2002). In: Blood, Vol. 100, no. 11, p. 794A (2002)
Permanent URL http://hdl.handle.net/2078.1/61659